Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcelAkshay Sharma, Haydar Frangoul, Franco Locatelli et al.|Blood Advances|2025Cited by 4
Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Haydar Frangoul, Antonis Kattamis et al.|Blood|2024Cited by 4
Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcelJosu de la Fuente, Franco Locatelli, Haydar Frangoul et al.|Blood Advances|2025Cited by 3
Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell DiseaseHaydar Frangoul, Stephan A. Grupp, Franco Locatelli et al.|Blood|2024Cited by 3
Durable Clinical Benefits in Transfusion-Dependent Β-Thalassemia with Exagamglogene AutotemcelHaydar Frangoul, William Hobbs, Franco Locatelli et al.|Transplantation and Cellular Therapy|2025Cited by 1